GlassScriptPhysician profile
Ron Gilat
NPI 1568177418
$16,122.86
in general payments reported to CMS, 2019-2025
7 companies · $291 in 2025
The $291 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $16K · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $9,500 · Travel and Lodging: $3,944 · Food and Beverage: $2,679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $9,500.00 |
| Travel and Lodging | $3,943.66 |
| Food and Beverage | $2,679.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,808.53 | 2024 | Q-Fix, Spatial Frame, Bone Anchors With Arthroscopic Delivery System |
| Stryker Corporation | $2,250.88 | 2024 | Blueprint Patient Specific Instrumentation, Alphavent, Aequalis Perform Reversed |
| Arthrex, INC. | $1,266.86 | 2024 | |
| Medical Device Business Services, INC. | $1,093.82 | 2024 | |
| Suvon Surgical LLC | $583.11 | 2024-2025 | |
| Lifenet Health | $102.56 | 2024 | Quadlink, Graftlink Ts |
| Lightbody Medical Technologies INC | $17.10 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Gilat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.